Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP-N-acetylglucosamine transporter (SLC35A3) is a membrane-bound transporter protein of the solute carrier (SLC) family located in the Golgi apparatus. It functions primarily to move UDP-N-acetylglucosamine (UDP-GlcNAc) from the cytosol into the Golgi lumen, operating as an antiporter and exchanging UDP-GlcNAc for UMP[2][4]. This action supplies glycosyltransferases in the Golgi with the substrate required for the biosynthesis of branched N-glycans and keratan sulfate[2][4]. SLC35A3 is crucial for normal cell growth, development, and protein glycosylation. Mutations are linked to congenital glycosylation disorders, intellectual disability, epileptic encephalopathy, and skeletal abnormalities in humans and cattle[2][3]. In cancer, altered expression of SLC35A3 impacts cell proliferation, invasion, apoptosis, and immune cell infiltration, making it a potential biomarker and therapeutic target[1]. The transporter may also form functional complexes with other SLC35 proteins, integrating signals relevant for Golgi function and cellular metabolism[3].
Not established for drugs, but modulation would theoretically alter UDP-GlcNAc flux into the Golgi, affecting glycosylation, cell proliferation, and apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-N-acetylglucosamine transporter (SLC35A3).